 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 March 1996 | Volume 124 Issue 5 | Pages 505-508
Considerable evidence links elevated blood cholesterol levels to the development of atherosclerosis. The National Cholesterol Education Program (NCEP) has recently published revised guidelines for detecting and treating hypercholesterolemia in adults. Included in these guidelines is the recommendation that all adults older than 20 years of age know their cholesterol levels. Under the NCEP guidelines, knowledge of cholesterol levels, even if the levels are elevated, does not automatically lead to drug therapy; on the other hand, under these guidelines, adults are not automatically excluded from treatment simply on the basis of age or sex. The guidelines presented by the American College of Physicians in this issue differ from the NCEP guidelines in that they recommend only limited screening, primarily for middle-aged men. This recommendation is based in part on the assumption that overuse of cholesterol-lowering drugs will otherwise become a problem. In fact, a major current problem is underuse of cholesterol-lowering medications, even in patients at high risk for coronary events. The guidelines proposed by the College minimize large elements of the database linking cholesterol to atherogenesis and make unwarranted and unproven assumptions about physician behavior. In its rationale, its potential consequences, and the process by which it was derived, this policy is in error and should be rejected.
Author and Article Information
From Tulane University Medical Center, New Orleans, Louisiana. For the current author address, see end of text.
PERSPECTIVE
Cholesterol Agonistics
Requests for Reprints: John C. LaRosa, MD, Tulane University Medical Center, 1430 Tulane Avenue, SL-76, New Orleans, LA 70112.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  J. C. LaRosa Means and Ends of Statins and Low-Density Lipoprotein Cholesterol Lowering J. Am. Coll. Cardiol., July 31, 2007; 50(5): 419 - 420. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. LaRosa Prevention and Treatment of Coronary Heart Disease: Who Benefits? Circulation, October 2, 2001; 104(14): 1688 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stamler, M. L. Daviglus, D. B. Garside, A. R. Dyer, P. Greenland, and J. D. Neaton Relationship of Baseline Serum Cholesterol Levels in 3 Large Cohorts of Younger Men to Long-term Coronary, Cardiovascular, and All-Cause Mortality and to Longevity JAMA, July 19, 2000; 284(3): 311 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Gotto Jr and S. M. Grundy Lowering LDL Cholesterol : Questions From Recent Meta-Analyses and Subset Analyses of Clinical Trial DataIssues From the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, Ninth Council Meeting Circulation, March 2, 1999; 99 (8): e1 - e7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Lemaitre, C. D. Furberg, A. B. Newman, S. B. Hulley, D. J. Gordon, J. S. Gottdiener, R. H. McDonald Jr, and B. M. Psaty Time Trends in the Use of Cholesterol-Lowering Agents in Older Adults: The Cardiovascular Health Study Arch Intern Med, September 14, 1998; 158(16): 1761 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 New Screening Guidelines Fuel Cholesterol Debate Journal Watch Cardiology, April 1, 1996; 1996(401): 6 - 6. [Full Text]
|
|
|
|
 |
|
 ACP Stops Urging Routine Cholesterol Screens for Young Adults Journal Watch Women's Health, April 1, 1996; 1996(401): 8 - 8. [Full Text]
|
|
Article
